As a result , the FDA decided to decrease the recommended starting dose of Eszopiclone , as sold by Sunovion under the brand name Lunesta , from 2 mg to 1 mg . FDA : The recommended starting dose for Lunesta should be 1 mg , not 10 mg . It targets patients showing ` ` severe next - day psychomotor and cognitive deficit '' Lunesta is the ` ` No . 1 prescribed branded sleep aid , '' its website says .
FDA : The recommended starting dose for Lunesta should be 1 mg , not 10 mg . It targets patients showing ` ` severe next - day psychomotor and cognitive deficit '' Lunesta is the ` ` No . 1 prescribed branded sleep aid , '' its website says .